FDA Law Blog

JANUARY 6, 2022

In general, EKRA prohibits, knowingly and willfully, soliciting, receiving, paying or offering kickbacks in exchange for referring to, inducing a referral to, or using the services of a recovery home, clinical treatment facility, or laboratory. S&G Labs Haw., The Eliminating Kickbacks in Recovery Act (“EKRA”). 18 U.S.C. §

Lab Testing 52

Lab Testing Referral Individual Patient-Centered 52

FDA Law Blog

JANUARY 6, 2022

In general, EKRA prohibits, knowingly and willfully, soliciting, receiving, paying or offering kickbacks in exchange for referring to, inducing a referral to, or using the services of a recovery home, clinical treatment facility, or laboratory. S&G Labs Haw., The Eliminating Kickbacks in Recovery Act (“EKRA”). 18 U.S.C. §

Lab Testing 40

Lab Testing Individual Referral Patient-Centered 40

GeriPal

FEBRUARY 6, 2025

We now have biomarkers that can reasonably approximate the degree of amyloid build-up in the brain with a simple blood test. We have two new FDA-approved medications that reduce that amyloid buildup and modestly slow down the progression of the disease. So I get all the referrals from my great colleagues in primary care.

Primary Care 97

Primary Care Diagnosis Screening IT 97

GeriPal

SEPTEMBER 7, 2023

So I will say that it’s challenging, because we don’t have, unlike City of Hope, we don’t have a big team like they do of geriatricians and palliative care physicians, who can screen these older adults or help with management. Mazie, I know it changes locale to locale, because your referral sources are going to be different.

Patient-Centered 130

Patient-Centered IT Patients Clinic 130

PEMBlog

MAY 9, 2024

Obviously, you should ask about immunization status and whether or not the child has any underlying medical or neurologic problems or developmental delay. So what’s the evaluation and management for simple febrile seizures? How do we evaluate and manage them? There’s a tenfold increase.

Illness 59

Illness Vaccination Families Family 59